Advancing Global Collaboration in LDLT
Live Demonstration: Pediatric LDLT----Renji Hospital, Shanghai Jiao Tong University School of Medicine
All iLDLTG Council Members
Council Meeting
Council Meeting
大会开幕式
全体会议-主题演讲
Session 1(A) A Global Perspective of LDLT
Q&A (5 min)
Session 1(B) Technical Considerations in Minimally Invasive Donor Hepatectomy
How to establish a Robotic-assisted Donor Hepatectomy Program
Q&A (5 min)
Session 1(C) Transplant Oncology
Liver transplantation for hepatocellular carcinoma: surgical technique and innovations
Improving transplantibility for locally advanced HCC: the Hong Kong approach
Q&A (5 min)
午餐
Session 1(D) Technical Considerations in Recipient Surgery in LDLT
Q&A (10 min)
Coffee Break
Session 1(E) ILLS/iLDLTG Expert Discussion on MIDH
Group 1: Position and Port sites
钟成鹏
【中国】
Taizo Hibi
【日本】
Worakitti Lapisatepun
【泰国】
Group 2: Hilum dissection: portal vein, hepatic artery
Silvia Silva
【葡萄牙】
Thanh Le Van
【越南】
Sreejith Sreekumar
【印度】
Rajesh Rajalingam
【印度】
Taiga Wakabayashi
【日本】
Group 3: Parenchymal hepatic transection
Fabrizio di Benedetto
【意大利】
Yee Lee Cheah
【美国】
Jinsoo Rhu
【韩国】
Catherine Teh
【菲律宾】
Daniel Cherqui
【法国】
Group 4: Bile duct division
Yuta Abe
【日本】
罗 毅
【中国】
Seisuke Sakamoto
【日本】
Amar Gupta
【美国】
Group 5: Vascular division and graft out
Marco Vivarelli
【意大利】
Marco Spada
【意大利】
Juan Pablo Rocca
【美国】
Mukesh Kumar
【印度】
Fabrizio Di Francesco
【意大利】
Brian Goh Kim Poh
【新加坡】
Group 6: Anesthesia and Pain control
Justin Sangwook Ko
【美国】
David Victor
【美国】
Session 2(A) Transplant Pathology
Post-Liver Transplant Complications: Beyond Reiection and Recurrent Disease
Evolving Concepts in Liver Allograft Pathology: Insights from the Banff Liver Group
Liver allograft rejection in living donor liver transplant (LDLT) recipients
Q&A (10 min)
Coffee break
Session 2(B) Dealing with Marginal Donors in LT
Long-term outcomes of LT recipients using Hepatitis virus-positive donor liver
From Assessment to Donation: Hepatologist’s Insights on Preparing Living Liver Donors
Q&A (10 min)
Session 3(A) Advanced Technology in LT
Advances in Imaging Techniques in Liver to Achieve Precision Liver Surgery
The prediction of hcc recurrence after liver transplantation based on radiomics
Integrated, intelligent and international hospital establishment for higher quality clinical medical care
Q&A (5 min)
Session 3(B) Xenotransplant
Q&A (5 min)
Session 3(C) Expanding the Donor Pool in LT
Advancing Domino Liver Transplantation: Challenges, Strategies, and Future Perspectives
Waste-to-Resource Strategy in Liver Transplantation: Utilizing Discarded Partial Hepatectomy Grafts
Q&A (5 min)
午餐研讨会
Optimizing immunosuppression: a path to consistency, innovation, and improved outcomes
午餐研讨会
Tacrolimus in focus: Striking the optimal balance through data-driven care and personalization
Session 3(D) Basic Science-Transplant Immunology
Donor Quality, Preservation, and Short-Term Outcomes in Liver Transplant: A Single-Cell and Spatial Analysis of Ischemia-Reperfusion Injury
EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance by targeting alloreactive CD4+ T cells
The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection
Q&A (10 min)
Session 3(E) Oral Abstract Session (Young Investigator Award 2025)
Graft inflow modulation in living donor liver transplantation
Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation
SEVEN-DAY CREATININE: A CRYSTAL BALL FOR KIDNEY FATE AFTER LIVER TRANSPLANT
Perioperative Management, Ethical Concerns, and Outcomes of Pediatric Domino Liver Transplants from Maple Syrup Urine Disease Donors
Evaluation Of Thrombocytopenia and Platelet Transfusion in Liver Transplant Recipients at a Quaternary Care Centre in South India
Peri-operative risk factors and outcomes in acute-on-chronic liver-failure (ACLF) patients undergoing living donor liver transplantation (LT)
Is a Functional Liver Remnant Volume Below 30% an Absolute Contraindication for Laparoscopic Living Liver Donors?
The Infection Puzzle in Liver Transplantation: Risk Factors, Outcomes and Clinical Strategy
Living Donor Liver Transplantation for Unresectable Colorectal Liver Metastasis – The University of Rochester Experience
Impact of Cold Ischemic Time on Rejection After Liver Transplantation: Is There a Safe Wondow?
Antioxidant Therapy for Prevention of Ischemia-Reperfusion Injury in Living Donor Liver Transplantation
Does GRWR Really Matters when Graft Weight is More than 650 gms in Living donor Liver Transplantation ????
Global Outcomes of Open versus Laparoscopic versus Robotic Donor Hepatectomy: A Prospective Study from the International LDLT Registry (LDLTregistry.org)
Renal Recovery Benefit of Living Donor Compared to Deceased Donor Liver Transplantation in High-MELD(≥35) Recipients: A Propensity Score-Matched Study
Clinical heterogeneity of refractory ascites after pediatric liver transplantation modulates allograft rejection risk
Mapping the Immunometabolic Landscape: Dual Axes of CCL3-Driven Macrophage Polarization and Succinate Signaling Drive Fibrosis in Pediatric Liver Transplant Recipients
Circadian Timing of Liver Transplantation Influences the Rejection Related Injury: A Retrospective Cohort Study
Mechanism of liver circFADS2 inhibiting rejection after liver transplantation in children
CRKP/MRSA Colonization Predicts Early Post-Liver Transplant Infection in Children: A Retrospective Matched Cohort Study
数智创新 肝愈氏界-肝癌肝移植高峰论坛
第一篇章:数智创新
第二篇章:肝愈氏界
大会总结
大会总结
郑树森
【中国】
午餐研讨会
“移路有约”肝移植技术及肝癌规范化论坛
开幕式
徐 骁
【中国】
Section 1 肝移植关键技术研讨
Endo Lab创新工坊
Section 2 肝癌规范化多学科建设
大会总结
大会总结
徐 骁
【中国】
第一节
第二节
Session 1 (F) Graft Matching in LDLT
Q&A (10 min)
Session 1(G) Paediatric LT -- Key Issues to consider
Indication of liver transplantation for metabolic liver disease in pediatric patients
Auxiliary Liver Transplantation for the Treatment of Acute Liver Failure in Children
Q&A (10 min)
iLDLTG GENERAL ASSEMBLY
午餐研讨会
Session 1(H) Vanguard Project Presentation(10 min. presentations with 5 minutes Q&A)
Session 1(I) Video demonstration
How to lmplant Modified Right Lobe Graft having V5,V8, and Inferior Right
闭幕式
Session 2(E) Immunological Considerations in Liver Transplantation
Donor-derived Regulatory DC infusion in Immune Tolerance: what we know
Q&A (10 min)
Session 2(F) Advances in Machine Perfusion in LT
Q&A (10 min)
午餐研讨会
Session 2(G) Peri-operative Considerations in Liver Transplantation
What is the timing of CBP after liver transplantation in critical liver failure recipients?
Diagnosis, Treatment, and Research of Severe Peri-operative Infections in Liver Transplantation
Q&A (10 min)
Session 2(H) Cell & Gene therapy -- From Bench to Bedside
From Lab to Clinic: Translating Bioengineered Liver Organoids for Precision Modeling and Regeneration
Progenitor Hepatocytes in Liver Disease: Therapeutic Potential and Translational Advances
Q&A (10 min)
第一节
第二节
茶歇
第三节
第四节
午餐研讨会
第一节
第二节
第三节
一、胰岛暨再生胰岛移植
“Beyond Immunosuppression: Next-Generation Cell Therapies for T1DM(40 years anniversary of the invention of the Ricordi Chamber and Automated method)”
二、心肺胰腺小肠移植
三、胰岛移植+再生/异种胰岛
主旨:聚焦·赋能·融合——构建高质量移植护理新格局
致辞
奚慧琴
【中国】
集体照
探索前沿护理模式,赋能移植护理发展
讨论
茶歇
深化专业能力与质量把控,引领移植护理专科建设
讨论